tradingkey.logo
tradingkey.logo
Search

Arcadia Biosciences Inc

RKDA
Add to Watchlist
0.218USD
-0.004-1.80%
Close 11-13 16:00(ET)
525.38KMarket Cap
LossP/E TTM
After-hours 19:27 (ET)0.196USD-0.021-9.68%

RKDA Financials

See Arcadia Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
525.38K
Dividend TTM
0.00
P/E TTM
-0.04
EPS TTM
-5.72
Revenue
4.86M
Net Profit
-7.04M
ROE
-158.15%
ROA
-101.82%
Arcadia Biosciences Inc Earnings Date
Latest Release
Nov 12, 2026
EPS / Forecast
0.29/-0.46
Revenue / Forecast
1.62M/2.40M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-53.78%0.29
35.79%-2.09
-210.65%-2.11
67.29%-0.97
152.97%0.63
-518.88%-3.26
206.92%1.90
-42.10%-2.98
37.40%-1.18
28.50%0.78
83.61%-1.78
66.74%-2.10
---1.89
--0.61
---10.86
---6.30
---19.37
----
----
----
Revenue
24.35%1.62M
-0.82%1.44M
-8.33%1.10M
-25.90%901.00K
-15.29%1.30M
11.41%1.46M
21.58%1.20M
56.50%1.22M
18.41%1.54M
0.69%1.31M
-19.89%987.00K
4.44%777.00K
-17.32%1.30M
-66.38%1.30M
-61.74%1.23M
-65.73%744.00K
-33.92%1.57M
174.59%3.86M
288.89%3.22M
-69.55%2.17M
Net Profit
105.02%1.75M
-40.56%-6.27M
-268.72%-4.38M
67.13%-1.34M
153.10%856.00K
-520.17%-4.46M
207.26%2.60M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
32.78%-2.85M
10.46%-2.57M
121.79%823.00K
-109.09%-9.38M
54.28%-4.24M
-31.82%-2.87M
28.21%-3.78M
-318.08%-4.49M
-204.32%-9.28M
Net Margin
64.88%108.40%
-41.73%-434.23%
-284.06%-398.64%
55.34%-148.28%
185.49%65.75%
-316.30%-306.39%
325.73%216.58%
-470.70%-331.99%
-56.21%-76.90%
-41.77%141.65%
87.16%-95.95%
86.39%-58.17%
---49.23%
--243.25%
---747.00%
---427.42%
---114.59%
----
----
----
Gross Margin
65.27%53.06%
0.83%43.73%
-15.76%36.36%
-33.39%21.31%
-25.12%32.10%
-15.84%43.37%
-17.43%43.17%
-58.50%31.99%
-23.97%42.88%
3.30%51.53%
13.60%52.28%
-75.53%77.09%
--56.39%
--49.88%
--46.02%
--315.05%
--22.07%
----
----
----
Debt to assets ratio
77.30%5.58%
--4.46%
--4.94%
----
--3.15%
----
----
----
----
--0.00%
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
Revenue
24.35%1.62M
-0.82%1.44M
-8.33%1.10M
-25.90%901.00K
-15.29%1.30M
11.41%1.46M
21.58%1.20M
56.50%1.22M
18.41%1.54M
0.69%1.31M
-19.89%987.00K
4.44%777.00K
-17.32%1.30M
-66.38%1.30M
-61.74%1.23M
-65.73%744.00K
-33.92%1.57M
174.59%3.86M
288.89%3.22M
-69.55%2.17M
Operating profit
40.45%-839.00K
91.72%-496.00K
36.15%-779.00K
39.67%-1.38M
12.27%-1.41M
-196.53%-5.99M
21.39%-1.22M
-105.50%-2.28M
-40.26%-1.61M
-38.93%-2.02M
59.82%-1.55M
37.87%-1.11M
71.31%-1.15M
58.46%-1.45M
16.28%-3.86M
59.09%-1.79M
40.14%-3.99M
48.97%-3.50M
9.46%-4.61M
-2908.97%-4.36M
Net Profit
105.02%1.75M
-40.56%-6.27M
-268.72%-4.38M
67.13%-1.34M
153.10%856.00K
-520.17%-4.46M
207.26%2.60M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
32.78%-2.85M
10.46%-2.57M
121.79%823.00K
-109.09%-9.38M
54.28%-4.24M
-31.82%-2.87M
28.21%-3.78M
-318.08%-4.49M
-204.32%-9.28M
Current assets
-45.61%4.56M
-24.28%5.74M
-41.57%5.17M
-31.23%6.36M
-21.70%8.39M
-39.05%7.58M
-24.02%8.85M
-38.27%9.24M
-46.46%10.71M
-46.72%12.43M
-57.21%11.64M
-41.05%14.97M
-33.38%20.01M
-22.35%23.34M
-13.63%27.20M
-28.23%25.40M
-31.49%30.03M
-40.97%30.06M
-44.36%31.50M
11.65%35.39M
Total current liabilities
-44.29%1.27M
-10.49%1.65M
-38.40%1.36M
-19.66%2.06M
-1.85%2.29M
-31.84%1.84M
-23.00%2.22M
-28.61%2.56M
-40.08%2.33M
-34.05%2.70M
-29.75%2.88M
-14.71%3.59M
-4.10%3.88M
-13.69%4.09M
-14.81%4.10M
-16.49%4.21M
-37.57%4.05M
-38.05%4.74M
-14.38%4.81M
-20.18%5.04M
Total assets
-45.06%4.72M
-24.33%5.89M
-59.02%5.32M
-51.57%6.55M
-43.68%8.58M
-55.16%7.79M
-19.05%12.99M
-31.40%13.52M
-35.05%15.24M
-35.19%17.37M
-47.23%16.05M
-31.87%19.70M
-31.93%23.47M
-23.45%26.80M
-21.62%30.41M
-34.15%28.92M
-41.79%34.47M
-50.55%35.01M
-45.20%38.80M
-7.24%43.92M
Total liabilities
-26.36%2.31M
61.60%5.26M
-40.32%2.44M
-67.01%2.41M
-38.32%3.14M
-43.91%3.25M
-26.57%4.08M
4.17%7.29M
-36.89%5.09M
-36.01%5.80M
-59.45%5.56M
-12.72%7.00M
-14.67%8.07M
10.05%9.07M
60.31%13.72M
-36.94%8.02M
-50.25%9.46M
-70.70%8.24M
-65.90%8.56M
-32.32%12.72M
Total equity
-55.85%2.40M
-86.04%633.00K
-67.60%2.88M
-33.47%4.14M
-46.37%5.44M
-60.81%4.53M
-15.05%8.90M
-51.01%6.22M
-34.09%10.15M
-34.77%11.57M
-37.20%10.48M
-39.22%12.70M
-38.45%15.40M
-33.76%17.73M
-44.81%16.69M
-33.00%20.90M
-37.80%25.02M
-37.28%26.77M
-33.83%30.24M
9.26%31.20M
Net operating income
-397.67%-1.28M
84.31%-319.00K
30.79%-1.10M
61.02%-861.00K
85.33%-257.00K
17.22%-2.03M
50.53%-1.59M
46.71%-2.21M
39.27%-1.75M
48.81%-2.46M
7.39%-3.21M
-75.93%-4.14M
14.42%-2.88M
-42.59%-4.80M
29.05%-3.47M
64.62%-2.36M
59.23%-3.37M
46.01%-3.37M
-3.78%-4.88M
1.35%-6.66M
Net investment
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.62%250.00K
12400.00%500.00K
4736.54%2.52M
3500.00%180.00K
198.45%4.64M
-98.73%4.00K
-81.49%52.00K
-98.53%5.00K
-9925.00%-4.72M
-57.83%315.00K
501.43%281.00K
267.16%341.00K
-99.72%48.00K
254.02%747.00K
-102.45%-70.00K
Net financing
-5600.00%-55.00K
--3.54M
35780.00%1.79M
--0.00
-75.00%1.00K
--0.00
0.00%5.00K
--0.00
-42.86%4.00K
--0.00
-99.91%5.00K
--0.00
-99.84%7.00K
--0.00
137525.00%5.50M
100.00%0.00
21400.00%4.51M
100.00%0.00
-99.98%4.00K
-101.47%-114.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total revenue reached 4.86M, with a year-on-year change of 5.04M.

What are the current assets of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its current assets were 6.36M, with a year-on-year change of -31.23.

What are the total assets of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total assets of Arcadia Biosciences Inc were 6.55M, with a year-on-year change of -51.57.

What are the total liabilities of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total liabilities of Arcadia Biosciences Inc were 2.41M, with a year-on-year change of -67.01.

What is the total equity of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total equity of Arcadia Biosciences Inc was 4.14M, with a year-on-year change of -33.47.

What is the net operating income of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net operating income of Arcadia Biosciences Inc was -9.99M, with a year-on-year change of -34.02.

What is the net investment of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net investment of Arcadia Biosciences Inc was 750.00K, with a year-on-year change of -89.78.

What is the net financing of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net financing of Arcadia Biosciences Inc was 6.00K, with a year-on-year change of -33.33.

What is the Earnings Per Share (EPS) of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.71, with a year-on-year change of 66.88.

What is the net income of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net income was -2.34M, with a year-on-year change of 66.77.

What is the net margin of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net profit margin was -48.15, with a year-on-year change of 43.73.

What is the gross margin of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its gross margin was 36.23, with a year-on-year change of -18.26.

What is the debt-to-asset ratio of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 4.12, with a year-on-year change of 106.49.

What is the Return on Equity (ROE) of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -45.14, with a year-on-year change of 0.33.

What is the Return on Assets (ROA) of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -23.32, with a year-on-year change of 10.28.

What is the operating profit of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its operating profit was -9.99M, with a year-on-year change of -34.02.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.